MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/107.5/0.1/20.12.24 Stock

Warrant

DE000MG4D2T5

Real-time Bid/Ask 04:41:53 2024-07-03 EDT
0.123 EUR / 0.201 EUR +17.39% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/107.5/0.1/20.12.24
Current month-0.72%
1 month-77.00%
Date Price Change
24-07-02 0.138 -12.66%
24-07-01 0.158 +13.67%
24-06-28 0.139 -7.95%
24-06-27 0.151 +7.09%
24-06-26 0.141 -4.73%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 02:52 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2T
ISINDE000MG4D2T5
Date issued 2024-05-16
Strike 107.5 $
Maturity 2024-12-20 (171 Days)
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.32
Lowest since issue 0.134
Spread 0.022
Spread %13.50%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus